EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Understanding Sorafenib-Induced Cardiovascular Toxicity: Mechanisms and Treatment Implications

Jue Li, Lusha Zhang, Teng Ge, Jiping Liu, Chuan Wang, Qi Yu iD

Drug Design, Development and Therapy · 2024

DOI: 10.2147/dddt.s443107 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Jue Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Research Center of Brain Health Industry of Chinese Medicine, Key Laboratory of Pharmacodynamics and Material Basis of Chinese Medicine o…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Antineoplastic Agents, Liver Neoplasms, Kidney Neoplasms. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularAntineoplastic AgentsLiver NeoplasmsKidney NeoplasmsHypertensionHumansSorafenibVascular Endothelial Growth Factor ANiacinamidePhenylurea CompoundsReceptors, Vascular Endothelial Growth FactorProtein Kinase Inhibitors

Stichwörter der Autor:innen

cancercardiovascular toxicityhypertensionsorafenibvascular endothelial growth factor receptor

Substanzen

SorafenibAntineoplastic AgentsVascular Endothelial Growth Factor ANiacinamidePhenylurea CompoundsReceptors, Vascular Endothelial Growth FactorProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Engineering Research Center of Brain Health Industry of Chinese Medicine, Key Laboratory of Pharmacodynamics and Material Basis of Chinese Medicine of Shaanxi Administration of Traditional Chinese Medicine, Pharmacology…
  • Shaanxi Key Laboratory of Ischemic Cardiovascular Diseases and Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an, 710021, People's Republic of China.

ORCID-Profile: Qi Yu

Zitieren

APA

Li, J., Zhang, L., Ge, T., Liu, J., Wang, C., & Yu, Q. (2024). Understanding Sorafenib-Induced Cardiovascular Toxicity: Mechanisms and Treatment Implications. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s443107

Vancouver

Li J, Zhang L, Ge T, Liu J, Wang C, Yu Q. Understanding Sorafenib-Induced Cardiovascular Toxicity: Mechanisms and Treatment Implications. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s443107

BibTeX
@article{Li2024,
  author = {Li, Jue and Zhang, Lusha and Ge, Teng and Liu, Jiping and Wang, Chuan and Yu, Qi},
  title = {Understanding Sorafenib-Induced Cardiovascular Toxicity: Mechanisms and Treatment Implications},
  journal = {Drug Design, Development and Therapy},
  year = {2024},
  doi = {10.2147/dddt.s443107}
}
Kostenlos starten →